个性化文献订阅>期刊> Biochemical Journal
 

Targeting human glutathione transferase A3-3 attenuates progesterone production in human steroidogenic cells

  作者 Raffalli-Mathieu, F; Orre, C; Stridsberg, M; Edalat, MH; Mannervik, B  
  选自 期刊  Biochemical Journal;  卷期  2008年414-1;  页码  103-109  
  关联知识点  
 

[摘要]hGSTA3-3 (human Alpha-class glutathione transferase 3-3) efficiently catalyses steroid Delta(5)-Delta(4) double-bond isomerization in vitro, using glutathione as a cofactor. This chemical transformation is an obligatory reaction in the biosynthesis of steroid hormones and follows the oxidation of 3 beta-hydroxysteroids catalysed by 3 beta-HSD (3 beta-hydroxysteroid dehydrogenase). The isomerization has commonly been ascribed to a supplementary function of 3 beta-HSD. The present study is the first to provide evidence that hGSTA3-3 contributes to this step in steroid hormone biosynthesis in complex cellular systems. First, we find glutathione-dependent Delta(5)-Delta(4) isomerase activity in whole-cell extracts prepared from steroidogenic cells. Secondly, effective inhibitors of hGSTA3-3 dramatically decrease the conversion of Delta(5)-androstene-3,17-dione into Delta(4)-androstene-3,17-dione in cell lysates. Thirdly, we show that RNAi (RNA interference) targeting hGSTA3-3 expression decreases by 30% the forskolin-stimulated production of the steroid hormone progesterone in a human placental cell line. This effect is achieved at low concentrations of two small interfering RNAs directed against distinct regions of hGSTA3-3 mRNA, and is weaker in unstimulated cells, in which hGSTA3-3 expression is low. The results concordantly show that hGSTA3-3 makes a significant contribution to the double-bond isomerization necessary for steroid hormone biosynthesis and thereby complements the indispensable 3 beta-hydroxysteroid oxidoreductase activity of 3 beta-HSD. The results indicate that the lower isomerase activity of 3 beta-HSD is insufficient for maximal rate of cellular sex hormone production and identify hGSTA3-3 as a possible target for pharmaceutical intervention ill steroid hormone-dependent diseases.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内